Atlas FDA

HEALTHTRONICS OSSATRON

FDA premarket approval P990086/S003 · decided 2003-03-14

Approval details

PMA number
P990086
Supplement
S003
Supplement type
Panel Track
Supplement reason
Labeling Change - Indications/instructions/shelf life/tradename
Trade name
HEALTHTRONICS OSSATRON
Generic name
Generator, shock-wave, for pain relief
Applicant
Sanuwave, Inc.
Date received
2001-11-05
Decision date
2003-03-14
Days to decision
494 days
Decision code
APPR
Product code
NBN
Advisory committee
Physical Medicine
Expedited review
No
Location
Alpharetta, GA
Statement
APPROVAL FOR THE HEALTHTRONICS OSSATRON. THE DEVICE IS INDICATED FOR USE FOR PERFORMING EXTRACORPOREAL SHOCK WAVE (ESW) TREATMENT IN PATIENTS WITH CHRONIC LATERAL EPICONDYLITIS (TENNIS ELBOW) THAT HAS FAILED TO RESPOND TO CONSERVATIVE TREATMENT. CHRONIC LATERAL EPICONDYLITIS IS DEFINED AS LATERAL EPICONDYLITIS THAT HAS PERSISTED FOR 6 MONTHS OR MORE WITH A HISTORY OF UNSUCCESSFUL CONSERVATIVE TREATMENT.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
dermaPACE System (DEN160037)Sanuwave, Inc.2017-12-28